18 October 2025. Building Community, EVENTS

WECAN marks its 10th anniversary in Berlin

WBCPC joined advocacy leaders in Berlin to mark 10 years of WECAN and highlight the network’s role in strengthening collaboration and patient advocacy across Europe.

WECAN was created to give patient organisations a stronger collective voice and to build the skills, alignment and structures needed to strengthen cancer advocacy across Europe and ultimately making a positive impact on the lives of people affected by cancer
Learn more
17 October 2025. Engaging in Advocacy, EVENTS

GCCN leads Shared Decision-Making roundtable at ESMO 2025

WBCPC joined the Global Cancer Coalitions Network and Ipsen at ESMO 2025 for a roundtable on strengthening shared decision-making in cancer care worldwide.

Shared decision-making cannot be delivered in theory. It must be supported in practice with adequate information, trusted dialogue and enabling structures that make patient participation in decisions concerning their treatment and care possible across all cancers and in all countries.
Learn more
14 October 2025. Engaging in Advocacy, EVENTS

Why EU Policy matters for patients: MEP Ondřej Dostál calls for better access and stronger prevention

At the World Bladder Cancer Patient Forum 2025, MEP Ondřej Dostál highlighted the need for greater awareness, prevention, and equitable access to care, calling for stronger EU collaboration to remove barriers and ensure timely treatment for all patients.

The patient movement is essential. We must ensure that in the next EU financial programme, there is space and support for the work that organisations like yours are doing.
Learn more
14 October 2025. EVENTS, Raising Awareness

Showcase of Bladder Cancer Awareness Month Grant Awardees

At the World Bladder Cancer Patient Forum 2025, the session Showcase of Bladder Cancer Awareness Month Grant awardees highlighted inspiring community-led projects from Malawi, Argentina, Colombia, and Kenya demonstrating how local action and creativity are driving global awareness and early detection of bladder cancer.

Learn more
14 October 2025. Engaging in Advocacy, EVENTS

Meaningful patient engagement in action

At the World Bladder Cancer Patient Forum 2025, the session Meaningful patient engagement in action explored how genuine collaboration between patients, advocates, researchers, and industry can transform care by making patient voices a driving force in every stage of decision-making.

Learn more
14 October 2025. Engaging in Advocacy, EVENTS

Making sense of medicine access

At the World Bladder Cancer Patient Forum 2025, the session Making sense of medicine access brought together patients, payers, and industry representatives to explore how innovation can truly reach those who need it most, turning scientific progress into timely and equitable access to care.

Learn more
14 October 2025. Engaging in Advocacy, EVENTS

Patient voice in Health Technology Assessments

At the World Bladder Cancer Patient Forum 2025, experts explored how stronger patient involvement in Health Technology Assessments can lead to more equitable and person-centred healthcare decisions.

Learn more
14 October 2025. EVENTS, Raising Awareness

Patient stories that drive change

At the World Bladder Cancer Patient Forum 2025, advocates Anita Andersen and Alessandro Boni shared their personal journeys and the lessons that continue to drive patient advocacy and awareness around the world.

Learn more
14 October 2025. Engaging in Advocacy, EVENTS

Latest developments in bladder cancer research

At the World Bladder Cancer Patient Forum 2025, Dr. Ashish Kamat and Prof. Hendrik Van Poppel shared key scientific and clinical advances shaping the future of bladder cancer diagnosis, treatment, and care.

Learn more
14 October 2025. Engaging in Advocacy, EVENTS

Driving policy progress in bladder cancer through collaboration

At the World Bladder Cancer Patient Forum 2025, a multi-stakeholder panel on Driving Policy Progress in Bladder Cancer through Collaboration explored how partnerships across research, policy, and industry can accelerate change for patients worldwide.

Learn more